Normally, this pathway is inhibited by the PATCH 1 gene, but when its activity is deficient due to mutations, a membrane protein called smoothing (SMO) is activated, which in turn activates the Hh pathway and ultimately causes tumorigenesis, BCC development, and progression. The gene discussed is SMO; the disease is skin basal cell carcinoma.